H2AX and cancer: Since phosphorylated H2AX is a marker of DNA damage, our findings suggested that roscovitine induces DNA damage in HPV+, but not HPV- cancer cells, which was undeniably verified utilizing the Comet assay (Figure 5), providing one possible mechanistic explanation for HPV+ HNSCC sensitivity.